Amolyt Pharma was acquired by AstraZeneca for up to $1.05bn
08 March 2024
08 March 2024
Total investments received (USD): N/A
Round value (USD): 1.05b
Round investors:
AstraZeneca
Company: Amolyt Pharma
Industry:
Health services
Pharma
Related deals
Alan raised €173m in Series F funding led by Belfius with Teachers' Venture Growth, Temasek, Coatue, and Lakestar chipping in.
Investments
08 September 2024
Akur8 raised $120 million in Series C funding led by One Peak Partners and joined by Partners Group and insider Guidewire Software.
Investments
05 September 2024
F2G raised a $100m round co-led AMR Action Fund and ICG, joined by Novo, Advent Life, Sofinnova, Forbion, Blue Owl, Morningside, and Merifin Capital.
Investments
01 September 2024
Exscientia to merge operations with Recursion from the US in a $668m deal
MA
02 August 2024
UnitySC was acquired by Merck for 155 million
MA
08 July 2024
Austria
Germany
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
Ireland
Italy
Portugal
Spain